Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

There, her team -- led by Dr. Pedro Piccinini, a plastic and reconstructive surgeon, and Dr. Maureen McEvoy, a breast surgical oncologist -- recommended McPherson undergo a new procedure called total ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DURHAM, N.C. (WNCN) — A Duke Researcher’s ...

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

If validated, the risk score could help guide decisions around surveillance and risk-reduction treatments for patients with in situ breast disease.

Doctors may soon be able to help women with early-stage breast cancer avoid unnecessary and aggressive treatments, thanks to ...

Actress Danielle Fishel made headlines last week when she announced that she had “very, very, very early” breast cancer. “It’s technically Stage 0,” the Boy Meets World star said on her podcast, “Pod ...